To explore Georgios Theodoridis' journey and insights in the field of analytical science, particularly high-performance liquid chromatography (HPLC) and metabolomics.
Approach:
Background: Theodoridis discusses his academic path in chemistry and physics, influenced by Greece's economic conditions in the 80s.
Career Development: He became involved in HPLC during his studies, helping to establish the first HPLC lab in his department.
Current Focus: Theodoridis is currently working on metabolomics related to type 2 diabetes, aiming to develop methods that can be applied in clinical settings.
Company Initiatives: He is involved with ThetaBiomarkers, a spinoff company focused on biomarker panels and providing alternative career paths in analytical science.
Key Findings:
HPLC remains a valid and widely used technique in clinical labs.
A fundamental understanding of physical chemistry is crucial for practitioners to avoid basic mistakes in analytical techniques.
Metabolomics is expected to grow significantly and become a standard part of clinical practice.
The lab has developed several technology-ready methods for diabetes research.
Interpretation:
Theodoridis emphasizes the importance of foundational knowledge in analytical chemistry and the potential of metabolomics in clinical applications.
Limitations:
The current diagnostic tools for diabetes do not adequately address the complexity of the disease.
Access to advanced analytical instrumentation is limited in academic settings compared to private companies.
Conclusion:
Theodoridis aims to enhance the translational impact of his research and promote the growth of analytical science through education and industry collaboration.
